BeStock  
Stocks › Biotechnology › TLX

Telix Pharmaceuticals TLX

US equityMarket cap rank #2480Biotechnology
$8.37 −$0.34 (-3.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.37 0.00%
Open$8.66
Prev close$8.71
Day range$8.37 – $8.70
Volume269.4K
Market cap$2.84B
P/E (TTM)86.3
Dividend yield–

Earnings

Average move on report day±7.1%last 4 reports
Closed higher4 of 4100% of the time
Best reaction+14.6%
Worst reaction1.3%

Stock move on the day after each report

+1.3%2024/Q4+10.2%2025/Q2+14.6%2025/Q4+2.5%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q219 Aug 2026After Market–+2.48%–
2025/Q419 Feb 2026After Market–+14.61%–
2025/Q220 Aug 2025After Market–+10.21%–
2024/Q419 Feb 2025After Market–+1.28%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By business line

  • Precision Medicine$621.93M 71.0%
  • Manufacturing Solutions$245.11M 28.0%
  • Therapeutics$9.27M 1.1%

By region

  • United States$784.91M 97.7%
  • China$9.83M 1.2%
  • Other countries$9.06M 1.1%

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$803.79M+55.6% YoY
Operating profit$18.05M-67.5% YoY
Net profit-$7.13M-121.2% YoY
Diluted EPS-$0.02-121.6% YoY
Free cash flow-$15.08M-1,487.3% YoY

Profitability & balance sheet

Gross margin53.7%
Operating margin5.3%
Net margin3.8%
Return on equity7.4%
Return on assets2.6%
Return on invested capital6.4%
Current ratio2.01
Liabilities / assets64.2%
Cash & investments$251.91M
Total debt$575.95M
Net cash (debt)-$324.04M

Discussion

No comments yet — be the first to weigh in on TLX.

Sign in to join the discussion.

Scroll to Top